3 days Ago By Qatar Tribune
Qatar tribune Tribune News Network Doha The Best of ASCO 2024 Annual Meeting, hosted by Hamad Medical Corporation (HMC) in partnership with the Qatar Cancer Society (QCS), concluded successfully, marking another milestone in advancing cancer care in Qatar. The conference, which focused on ‘Shaping Cancer Care Together’, provided a platform for participants to explore various topics. These comprised the management of common cancers such as breast, colon, lung, and prostate, as well as rare conditions like neurological, head and neck, urological, gynaecological cancers, and sarcomas.
Attendees had the opportunity to explore advancements in emerging therapeutics, including immunotherapy, molecular precision medicine, tumour biology, and new symptom management and survivorship approaches. Reflecting on the event’s success, Dr. Mohammed Ussama Al Homsi, deputy medical director for Education, Research, and Quality at the National Centre for Cancer Care and Research and Chairman of the Best of ASCO 2024 in Qatar, stated, “The Best of ASCO 2024 has once again proven to be an invaluable prospect for healthcare professionals to engage with the latest global research and treatment practices.
This event has reinforced our commitment to advancing cancer care in Qatar.” Dr. Anas Hamad, director of the Pharmacy Department at the National Centre for Cancer Care and Research and Chairman of the Organizing Committee for Best of ASCO 2024 in Qatar, emphasized the significance of collaboration and teamwork: “This year witnessed the highest number of attendees for our conference with more than 300 healthcare professionals, academics, students, and industry representatives participated.
” Copy 17/09/2024 10.
